Genscript Biotech
$43.72Change from previous close: −2.54%Absolute change: −$1.14
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- $99.7B
- Enterprise value
- $95.15B
- Forward P/E
- 77.4
- Price/book
- 3.13
- Price/sales
- 118.0
- EV/EBITDA
- 493.9
- EV/revenue
- 112.6
Profitability and growth
- Gross margin
- 52.0%
- Operating margin
- 12.3%
- Net margin
- -75.4%
- ROE
- -15.3%
- ROA
- 1.5%
- Revenue growth (year over year)
- -22.1%
Financial health
- Total cash
- $810.27M
- Total debt
- $343.53M
- Debt/equity
- 0.09
- Current ratio
- 1.53
- Quick ratio
- 1.33
Dividends
- Payout ratio
- 0.0%
- Ex-dividend date
- June 5, 2017
Analysts and estimates
- Average price target
- $30.66
- Median price target
- $32.01
- High price target
- $41.00
- Low price target
- $15.92
- Analysts with a price target
- 7
- Consensus
- Strong buy
- Forward EPS
- $0.56
- EPS estimate, current year
- $0.03
Shares and trading
- Beta
- 0.98
- Average volume
- 37.55M
- Shares outstanding
- 2.28B
- Float
- 1.41B
- Institutional ownership
- 30.1%
- Insider ownership
- 35.2%